Skip to main content
. 2014 Mar 21;306(11):H1495–H1506. doi: 10.1152/ajpheart.00978.2013

Fig. 4.

Fig. 4.

Bar graphs showing the effects of iv injection of a subthreshold dose (1 mg/kg) of the soluble guanylate cyclase (sGC) activator BAY 60-2770 on pulmonary and systemic arterial pressure and cardiac output before and after treatment with ODQ (5 mg/kg iv). *P < 0.05 compared with control.